Publications by Center Staff

2010

Dickerson BC, Eichenbaum H (2010).

2010

Luciano JS, Andersson B, Batchelor C, Bodenreider O, Clark T, Domarew C, Harland L, Jentzsch A, Kashyap V, Kos P, Kozlovsky J, Marshall MS, McCusker JP,  McGurk J, Ogbuji C, Pichler E, Powers RL, Prud’Hommeaux E, Samwald M, Schriml L, Tonellato PJ, Whetzel PL, Zhao J, Stephens S and Dumontier M (2010).

2010

Nelson PT, Kukull WA and Frosch MP (2010). Thinking outside the box:  Alzheimer-type neuropathology that does not map directly onto current consensus recommendations. J Neuropathol Exp Neurol; 69:  449-454. PMCID:  2892786.

2010

Coma M, Sereno L, Da Rocha-Souto B, Scotton TC, Espana J, Sanchez MB, Rodriguez M, Agullo J, Guardia-Laguarta C, Garcia-Alloza M, Clarimon J, Borrelli LA, Lleo A, Bacskai BJ, Saura CA and Hyman BT (2010). Trifulsal reduces dense-core plaque load, associated axonal alterations and inflammatory changes, and rescues cognition in a transgenic mouse model of Alzheimer's disease.

2010

Leritz EC, Salat DH, Milberg WP, Chapman CE, Grande LJ, Rudolph JL, Fischl B, Schnyer DM, Barber CE, Lipsitz L and McGlinchey RE (2010). Variation in blood pressure is associated with white matter microstructure but not cognition in African Americans. Neuropsychology; 24:  199-208. PMCID:  2849283.

2010

Salat DH, Tuch DS, Van der Kouwe AJ, Greve DN, Pappu V, Lee SY, Hevelone ND, Zaleta AK, Growdon JH, Corkin S, Fischl B and Rosas HD (2010).  White matter pathology isolates the hippocampal formation in Alzheimer’s disease. Neurobiol Aging; 31:  244-256.

2010

Bosco DA, Morfini G, Karabacak NM, Song Y, Gros-Louis F, Pasinelli P, Goolsby H, Fontaine BA, Lemay N, McKenna-Yasek D, Frosch MP, Agar JN, Julien JP, Brady ST and Brown RH Jr, (2010).  Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS.

2009

Hajjar I, Yang F, Sorond F, Jones RN, Milberg W, Cupples LA, Lipsitz LA (2009).  A novel aging phenotype of slow gait, impaired executive function, and depressive symptoms:  Relationship to blood pressure and other cardiovascular risks. J Gerontol A Biol Sci Med Sci; 64:  994-1001. PMCID:  2720888.

2009

Salloway S, Sperling R, Gilman S, Fox NC, Blennow K, Raskind M, Sabbagh M, Honig LS, Doody R, van Dyck CH, Mulnard R, Barakos J, Gregg KM, Liu E, Lieberburg I, Schenk D, Black R, Grundman M and Bapineuzumab 201 Clinical Trial Investigators (2009). A phase 2 multiple ascending dose trial of Bapineuzumab in mild to moderate Alzheimer disease. Neurology; 73:  2052-2053. PMCID:  2790221.

2009

Meyer-Luehmann M, Mielke M, Spires-Jones T, Stoothoff W, Jones P, Bacskai B and Hyman B (2009). A reporter of local dendritic translation shows plaque related loss of neural system function in APP transgenic mice.  J Neurosci; 29: 12636-40.